15 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... indicate preferred treatment ... limitation, further evaluation ... #Management #Pulmonary
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... and Management ... Abscess Management ... #Abscess #pulmonary ... #treatment #diagnosis
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... Pericardial tamponade, Pulmonary ... #inopressors #diagnosis ... #management #comparison ... #table
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
absence of intrinsic lung ... cirrhosis • Intra-pulmonary ... on radioactive lung ... ) on room air Treatment ... #management #treatment
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
Cardiogenic Shock - Management ... Checklist Evaluation ... 1 — Treat the lungs ... Revascularization, treatment ... #Checklist #CHF
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Evaluation is guided ... yield of available diagnostic ... The treatment of ... Management options ... 70% to 90% for a diagnosis
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #algorithm #management ... #table #foamed ... #heartfailure #chf ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... disease b) CHF ... unless prior heart/lung ... medical and surgical management ... stratification #diagnosis
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
MC: CNS CSF: • ... India ink prep CSF ... change in the lungs ... nails, bronchi, lungs ... #Management #Infections